High Dose BAYA1040 CR: a Long Term Extension Study
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.
Also called NCT01355367
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT01355367
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT01355367. Non-randomized; no masking; primary purpose treatment. Start 2011-01 (registry gives no type); primary completion 2011-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- High Dose BAYA1040 CR: a Long Term Extension Study
- Condition
- Hypertension
- Intervention (Drug)
- Nifedipine (Adalat, BAYA1040)
- Lead sponsor
- Bayer
Record details
- Record id
cardio:ct-nct01355367- Content hash
8ceffb70dd414e08396ef217563050012c2172e06256f62b5ec835b133931436